SUSTAINED RELEASED DELIVERY OF AMPHETAMINE SALTS

摘要

A PHARMACEUTICAL COMPOSITION COMPRISES A ONCE-A-DAY SUSTAINED RELEASE FORMULATION OF AT LEAST ONE AMPHETAMINE SALT WHICH PROVIDES MEAN PLASMA CONCENTRATION PROFILE ASPECTS IN HUMAN ADHD PATIENTS WHICH ARE SUBSTANTIALLY THE SAME AS THAT PROVIDED BY ADDERALL XR® TYPE PULSATILE FORMULATIONS.